Literature DB >> 15251556

Hypogonadism and methadone: Hypothalamic hypogonadism after long-term use of high-dose methadone.

R E de la Rosa1, J V Hennessey.   

Abstract

OBJECTIVE: To assess the relationship between hypogonadism and long-term administration of high-dose methadone.
METHODS: We present a case of a 47-year-old man with a history of heroin use and treatment with high doses of methadone (130 mg/day), who complained of gynecomastia and impotence. Baseline levels of serum luteinizing hormone (LH), serum follicle-stimulating hormone (FSH), plasma testosterone, and prolactin were determined, and then the response of gonadotropin levels to stimulation with gonadotropin-releasing hormone (GnRH) was examined at 30, 60, 90, 120, and 180 minutes.
RESULTS: Basal values of testosterone, LH, and FSH were below normal levels, whereas prolactin was normal. After administration of GnRH, the patient had a suboptimal increase in LH levels and lack of a response of FSH. When the daily dose of methadone was decreased to 40 mg, the patient's libido returned, and LH, FSH, and testosterone levels increased.
CONCLUSION: These findings could indicate the presence of (1) a direct effect of methadone on the hypothalamus that leads to an alteration in normal gonadotropin pulse patterns, or (2) a selective effect of methadone on the anterior pituitary that alters its response to GnRH, with either mechanism leading to a reversible, dose-related depression of testosterone levels.

Entities:  

Year:  1996        PMID: 15251556     DOI: 10.4158/EP.2.1.4

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  7 in total

1.  Finasteride and methadone use and risk of advanced hepatitis C related liver disease.

Authors:  Donna L White; Ali Hashmi; David J Ramsey; Jill Kuzniarek; Shahriar Tavakoli-Tabasi; Hashem B El-Serag
Journal:  Dig Dis Sci       Date:  2012-06-05       Impact factor: 3.199

2.  Opioids and endocrine dysfunction.

Authors:  Oliver Seyfried; Joan Hester
Journal:  Br J Pain       Date:  2012-02

3.  Relationship between sex hormones and cognitive performance in men with substance use.

Authors:  Mihail F Zilbermint; Amy B Wisniewski; Xiaoqiang Xu; Ola A Selnes; Adrian S Dobs
Journal:  Drug Alcohol Depend       Date:  2012-09-26       Impact factor: 4.492

Review 4.  The effects of opioids and opioid analogs on animal and human endocrine systems.

Authors:  Cassidy Vuong; Stan H M Van Uum; Laura E O'Dell; Kabirullah Lutfy; Theodore C Friedman
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

5.  Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of Bupropion as Treatment for Methadone-Emergent Sexual Dysfunction in Men.

Authors:  Anne Yee; Huai Seng Loh; Teng Aik Ong; Chong Guan Ng; Ahmad Hatim Sulaiman
Journal:  Am J Mens Health       Date:  2018-07-04

Review 6.  Testosterone deficiency in non-cancer opioid-treated patients.

Authors:  F Coluzzi; D Billeci; M Maggi; G Corona
Journal:  J Endocrinol Invest       Date:  2018-10-20       Impact factor: 4.256

7.  Metabolic and Addiction Indices in Patients on Opioid Agonist Medication-Assisted Treatment: A Comparison of Buprenorphine and Methadone.

Authors:  Igor Elman; Margaret Howard; Jacob T Borodovsky; David Mysels; David Rott; David Borsook; Mark Albanese
Journal:  Sci Rep       Date:  2020-03-27       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.